Jennifer Downing

Follow

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Quinolines and azaquinolines as inhibitors of CD38
- Patent number 11,952,377
- Issue date Apr 9, 2024
- Boehringer Ingelheim International GmbH
- Jennifer Downing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterobicyclic amides as inhibitors of CD38
- Patent number 11,535,621
- Issue date Dec 27, 2022
- Ribon Therapeutics, Inc.
- Laurie B. Schenkel
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38
- Publication number 20240279224
- Publication date Aug 22, 2024
- Boehringer Ingelheim International GmbH
- Jennifer Downing
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY
- Publication number 20240101540
- Publication date Mar 28, 2024
- Ribon Therapeutics, Inc.
- Nicholas Robert Perl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38
- Publication number 20230312586
- Publication date Oct 5, 2023
- Ribon Therapeutics, Inc.
- Laurie B. Schenkel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38
- Publication number 20220242862
- Publication date Aug 4, 2022
- Ribon Therapeutics, Inc.
- Jennifer Downing
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38
- Publication number 20210032251
- Publication date Feb 4, 2021
- Ribon Therapeutics, Inc.
- Laurie B. Schenkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE